Farhat, I., Rosolowski, M., Ahrens, K., Lienau, J., Ahnert, P., Pletz, M., . . . Group, t. C. S. Biomarkers troponin and procalcitonin in addition to CRB-65 enhance risk stratification in patients with community-acquired pneumonia. European Respiratory Society.
Chicago Style (17th ed.) CitationFarhat, Imrana, et al. Biomarkers Troponin and Procalcitonin in Addition to CRB-65 Enhance Risk Stratification in Patients with Community-acquired Pneumonia. European Respiratory Society.
MLA (9th ed.) CitationFarhat, Imrana, et al. Biomarkers Troponin and Procalcitonin in Addition to CRB-65 Enhance Risk Stratification in Patients with Community-acquired Pneumonia. European Respiratory Society.
Warning: These citations may not always be 100% accurate.